Sign in

CIK 0001649094

  • Large accelerated filer

Vaxcyte, Inc.

Sign in to watch
Ticker
PCVX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464233385
Phone
+1 650-837-0111
Business address
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
Former names
SutroVax, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,185,988
in 8 filings, $4.8M under 10b5-1 plans

Net −$5,185,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 88 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-06-01 Loxam Teri Director Grant or award · Stock Option (right to buy) +18,750 18,750
2022-06-01 Drapeau Anne S Director Grant or award +3,125 3,125
2022-06-01 Drapeau Anne S Director Grant or award · Stock Option (right to buy) +18,750 18,750
2022-06-01 Lukatch Heath Director Grant or award +3,125 3,125
2022-06-01 Lukatch Heath Director Grant or award · Stock Option (right to buy) +18,750 18,750
2022-06-01 Hirth Peter Director Grant or award +3,125 3,125
2022-06-01 Hirth Peter Director Grant or award · Stock Option (right to buy) +18,750 18,750
2022-06-01 Gilbert Halley E Director Grant or award +3,125 3,125
2022-06-01 Gilbert Halley E Director Grant or award · Stock Option (right to buy) +18,750 18,750
2022-05-23 Sauer Paul SVP Process Dev, Manufacturing Sale −3,000 $26.22 $79K 23,687
2022-05-20 Fairman Jeff VP, Research Sale −4,112 $25.50 $105K 321,227
2022-05-18 GUGGENHIME ANDREW President and CFO Exercise or conversion +3,100 $5.35 $17K 45,287
2022-05-18 GUGGENHIME ANDREW President and CFO Sale −2,520 $24.26 $61K 42,767
2022-05-18 GUGGENHIME ANDREW President and CFO Sale −580 $25.22 $15K 42,187
2022-05-18 GUGGENHIME ANDREW President and CFO Exercise or conversion · Stock Option (right to buy) −3,100 502,918
2022-05-16 PICKERING GRANT Chief Executive Officer Exercise or conversion +11,000 $1.79 $20K 714,894
2022-05-16 PICKERING GRANT Chief Executive Officer Sale −7,866 $23.76 $187K 707,028
2022-05-16 PICKERING GRANT Chief Executive Officer Sale −3,134 $24.28 $76K 703,894
2022-05-16 PICKERING GRANT Chief Executive Officer Exercise or conversion · Stock Option (right to buy) −11,000 234,450
2022-05-09 Eydelman Mikhail SVP, Gen Counsel & Corp Sec Grant or award · Stock Option (right to buy) +225,000 225,000

Page 48 of 51 · 1,004 trades